Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.94 USD | -1.45% |
|
+2.78% | +16.15% |
05-22 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
05-14 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.15% | 7.94B | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Insider Sold Shares Worth $156,408, According to a Recent SEC Filing